Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
VITA PHARMA LIMITED logo — Pioneering advanced treatments to address significant unmet...

VITA PHARMA LIMITED

Pioneering advanced treatments to address significant unmet medical needs in chronic kidney disease, diabetes, atherosclerosis, and Alzheimer's disease.

Founded 2001 2 employees Venture round Total: $94.00M Biotechnology, Health Care +1

General Information

Company Name VITA PHARMA LIMITED
Founded Year 2001
Employees 2
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with VITA PHARMA LIMITED. To contact VITA PHARMA LIMITED, visit vitaepharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About VITA PHARMA LIMITED

VITA PHARMA LIMITED, founded in 2001, is a clinical-stage biopharmaceutical company with the slogan "Pioneering advanced treatments to address significant unmet medical needs in chronic kidney disease, diabetes, atherosclerosis, and Alzheimer's disease." The company is dedicated to developing a portfolio of innovative, small molecule, top-tier compounds that target expansive markets with significant unmet medical needs. Its focus lies on conditions such as chronic kidney disease, diabetes, atherosclerosis, and Alzheimer's disease within the industries of Biotechnology, Health Care, and Pharmaceutical. The company secured a notable $15.00M Venture Round investment on 09 June 2009. This puts the company in a strong position to advance its clinical-stage developments and work towards addressing critical medical needs in various disease areas. Although information about the specific investors or the headquarters is not available, the recent investment demonstrates ongoing interest and confidence in the company's potential for growth and success within the biopharmaceutical industry.

Taxonomy: biopharmaceutical company, clinical-stage, chronic kidney disease, diabetes, atherosclerosis, Alzheimer's disease, innovative treatments, small molecule compounds, significant unmet medical needs, top-tier compounds, expansive markets, novel compounds, best-in-class compounds

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $15.00M -
09 Jun 2009
Series D $15.00M 4
New Enterprise Associates Atlas Venture Prospect Venture Partners
New Enterprise Associates, Atlas Venture +2
06 Nov 2007
Series C $15.00M 5
New Enterprise Associates Atlas Venture Prospect Venture Partners
New Enterprise Associates, Atlas Venture +3
14 Jul 2005
Series B $34.00M 1
Venrock
Venrock
04 Jan 2005
Series B $15.00M -
14 Jan 2004

VITA PHARMA LIMITED Alternatives & Competitors

View All Alternatives
VITA PHARMA LIMITED vs
MediciNova
MediciNova

Focused on innovative small-molecule therapeutics, addressing unmet medical needs with strategic all...

Post-IPO Equity
Biotechnology, Health and Wellness
VITA PHARMA LIMITED vs
Genocea Biosciences
Genocea Biosciences

Pioneering innovative vaccines and immunotherapies for critical unmet medical needs using advanced a...

Post-IPO Equity
Biotechnology, Health Care
VITA PHARMA LIMITED vs
Axerion Therapeutics
Axerion Therapeutics

Pioneering breakthrough therapies for Alzheimer's and spinal cord injuries through advanced neurolog...

Venture round
1 employees
Biotechnology, Health Care
View all alternatives

FAQ About VITA PHARMA LIMITED

Pioneering advanced treatments to address significant unmet medical needs in chronic kidney disease, diabetes, atherosclerosis, and Alzheimer's disease.
VITA PHARMA LIMITED was founded in 2001.
VITA PHARMA LIMITED operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on biopharmaceutical company, clinical-stage, chronic kidney disease and diabetes.
VITA PHARMA LIMITED has approximately 2 employees.
VITA PHARMA LIMITED has completed 5 funding rounds, raising a total of $94.00M. The latest funding stage is Venture round.
Top alternatives and competitors to VITA PHARMA LIMITED include MediciNova, Genocea Biosciences, Axerion Therapeutics, Synta Pharmaceuticals, DiaMedica Therapeutics Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
VITA PHARMA LIMITED and MediciNova are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for VITA PHARMA LIMITED, https://bouncewatch.com/company/vita-pharma-limited, updated 24 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes